Treatment Intermittent Periods Based on ctDNA-MRD（Circulating Tumor DNA-minimal Residual Disease） Status in Advanced HER2-Positive Breast Cancer
NCT07132502
·
clinicaltrials.gov ↗
NOT_YET_RECRUITING
Status
24
Enrollment
OTHER
Sponsor class
Conditions
Breast Cancer
Interventions
OTHER:
ctDNA MRD
Sponsor
Cancer Institute and Hospital, Chinese Academy of Medical Sciences